Insulin promotes vascular smooth muscle cell proliferation and apoptosis via differential regulation of tumor necrosis factor-related apoptosis-inducing ligand

Circulating level of TRAIL concentration is positively associated with endothelial function and increased by diabetic therapy in the newly diagnosed type 2 diabetic patients

(2013) Guangda Xiang et al.   CLINICAL ENDOCRINOLOGY

Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients

(2012) A. Bisgin et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells

(2012) In-Kyung Jeong et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: Mechanisms of PDGF-BB-mediated VSMC proliferation and migration

(2012) Nor Saadah M. Azahri et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Angiotensin II Shifts Insulin Signaling Into Vascular Remodeling From Glucose Metabolism in Vascular Smooth Muscle Cells

(2011) Hirofumi Hitomi et al.   AMERICAN JOURNAL OF HYPERTENSION

Insulin, Thrombin, ERK1/2 Kinase and Vascular Smooth Muscle Cells Proliferation

(2011) Esma R. Isenovic et al.   CURRENT PHARMACEUTICAL DESIGN

TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice

(2011) B. A. Di Bartolo et al.   DIABETOLOGIA

Association of soluble tumour necrosis factor-related apoptosis-inducing ligand levels with coronary plaque burden and composition

(2011) Spyridon Deftereos et al.   HEART

Insulin-mediated upregulation of KCa3.1 channels promotes cell migration and proliferation in rat vascular smooth muscle

(2011) Xing-Li Su et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults

(2010) Stefano Volpato et al.   ATHEROSCLEROSIS

Epigenetics

(2010) Mark E. Cooper et al.   CIRCULATION RESEARCH

TRAIL Promotes VSMC Proliferation and Neointima Formation in a FGF-2–, Sp1 Phosphorylation–, and NFκB-Dependent Manner

(2010) Jeffrey Chan et al.   CIRCULATION RESEARCH

The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients

(2010) S. Liabeuf et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Association of serum TRAIL level with coronary artery disease

(2010) Katsuhito Mori et al.   THROMBOSIS RESEARCH

Insulin-Like Growth Factor-1 Receptor Expression Masks the Antiinflammatory and Glucose Uptake Capacity of Insulin in Vascular Smooth Muscle Cells

(2009) Niels Engberding et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Insulin Regulation of Proliferation Involves Activation of AKT and ERK 1/2 Signaling Pathways in Vascular Smooth Muscle Cells

(2009) E. Isenovic et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction

(2009) Paola Secchiero et al.   PLoS One

TRAIL Stimulates Proliferation of Vascular Smooth Muscle Cells via Activation of NF-κB and Induction of Insulin-like Growth Factor-1 Receptor

(2008) Mary M. Kavurma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones

(2008) Solomon S. Solomon et al.   LIFE SCIENCES

Insulin-inhibited and stimulated cultured vascular smooth muscle cell migration are related to divergent effects on protein phosphatase-2A and autonomous calcium/calmodulin-dependent protein kinase II

(2007) Ming Yang et al.   ATHEROSCLEROSIS